In Brief: Cortecs
This article was originally published in The Gray Sheet
Cortecs: Receives 510(k) clearance from FDA for its Helisal point-of-care Helicobacter pylori rapid blood diagnostic kit. The kit uses a whole blood sample from a finger-stick to determine results within five minutes "without the use of any additional equipment," Cortecs says. Boehringer Mannheim will market the test in the U.S. under the name AccuStat H. pylori via an exclusive distribution agreement announced last year ("The Gray Sheet" Nov. 20, 1995, In Brief). In February, Quidel's Quick Vue rapid H. pylori whole blood finger-stick test became the first point-of-care H. pylori test to gain FDA clearance ("The Gray Sheet" March 4, In Brief)...
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.